1. United Kingdom Stocks

  2. •

    Basic Materials

  3. •

    Chemicals - Specialty
Victrex plc

Victrex plc

VTXPF
Victrex plcUS flagOther OTC
8.18
USD
- -
- -
712.68MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
2.63
2.98
3.1
2.96
3.39
3.8
3.34
3.06
3.59
3.92
3.53
3.41
3.41
Basic EPS, GAAP
0.86
0.95
0.98
0.97
1.16
1.29
1.07
0.63
0.84
0.88
0.71
0.2
0.32
Free Cash Flow per Basic Share
0.47
0.38
0.55
0.67
1.18
1.39
0.67
0.51
0.98
0.4
0.04
0.59
0.57
Dividend per Share
0.39
0.44
0.95
0.47
0.47
1.23
1.42
0.46
0.6
1.1
0.6
0.6
0.6
Book Value per Share
3.29
3.74
3.78
4.18
5.02
5.14
4.73
4.86
5.15
4.93
4.99
4.59
4.33
Tangible Book Value per Share
3.6
4.05
3.97
4.29
5.24
5.38
5.04
5.26
5.62
5.41
5.55
5.11
4.77
Basic Weighted Avg Shares
84
85
85
85
85
86
86
86
87
87
87
87
87
Sales/Revenue/Turnover
222
253
264
252
290
326
288
264
311
341
307
296
296
Operating Margin (%)
42.36
40.46
40.34
39.95
38.97
38.93
36.65
28.73
30.01
25.95
23.84
15.46
13.43
Depreciation Expense
10
10
13
16
18
18
17
21
22
22
22
23
25
Net Income, GAAP
73
80
84
82
100
111
92
54
73
76
62
17
28
Effective Tax Rate (%)
22.94
21.91
21.52
17.75
10.36
13.25
11.75
14.65
21.3
13.91
15.86
32.48
26.33
Profit Margin (%)
32.85
31.75
31.69
32.7
34.29
33.93
32.07
20.49
23.52
22.35
20.1
5.81
9.38
Working Capital
141
134
105
121
188
206
159
173
182
147
173
156
124
LT Debt
- -
- -
- -
- -
- -
- -
- -
6
14
29
43
41
30
Total Equity
314
353
359
389
478
490
462
481
512
491
501
462
431
Return on Invested Capital (%)
23.4
22.92
22.86
21.58
22.93
22.35
19.17
13.49
14.42
14.46
11.43
5.79
5.9
Return on Capital (%)
28.34
26.99
26.18
24.41
25.44
25.41
21.77
13.01
16.49
16.65
13.24
4.22
7.44
Return on Common Equity (%)
28.28
26.96
26.13
24.34
25.34
25.41
21.77
13.1
16.9
17.43
14.32
4.13
7.17

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2.22%
-2.01%
-6.59%
Free Cash Flow
148.66%
288.68%
-4.09%
Net Income, GAAP
-1.76%
1.93%
61.63%
Sales/Revenue/Turnover
1.71%
2.76%
0.07%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
296
2025
- -
- -
- -
- -
296
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.2
2025
- -
- -
- -
- -
0.32
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.6
2025
- -
- -
- -
- -
0.6
2026
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
James Mathew Routh
Full Time Employees
1,131
Sector
Basic Materials
Industry
Chemicals - Specialty
Address
Victrex Technology Centre Thornton-Cleveleys United Kingdom FY5 4QD
IPO Date
Feb 15, 2013
Website
victrexplc.com
Similar Companies
OrganoClick AB (publ) (ORGC.ST)
Tibet GaoZheng Explosive Co., Ltd. (002827.SZ)
Sika AG (0Z4C.L)
Evonik Industries AG (EVK.DE)
Rianlon Corporation (300596.SZ)
Plásticos Compuestos, S.A. (ALKOM.PA)
Business
Victrex plc manufactures and sells high-performance PEEK and PAEK-based polymer solutions, semi-finished and finished parts including pipes, films, fibres, composite tapes and thermoplastic components; offers specialist solutions for medical device manufacturers such as PEEK-OPTIMA for spine, arthroscopy, cranio-maxillofacial, trauma plates, knee implants and drug delivery applications; and provides VICTREX polymers like 450G PEEK, AE 250 for aerospace composites, XPI grades for e-mobility wire coatings and APTIV acoustic films for electronics. The company operates through Sustainable Solutions (encompassing aerospace, automotive, energy & industrial, electronics) and Medical segments, serving customers in automotive, aerospace, energy, electronics, industrial manufacturing & engineering and medical markets across more than 40 countries with facilities in the UK, Europe, North America, China, Japan and other Asian locations. Founded in 1993 and headquartered in Thornton Cleveleys, Lancashire, UK, Victrex focuses on six core markets aligned to global megatrends including climate change and technology breakthroughs; recent developments include new China manufacturing facilities reaching commercial production in late FY2024, Project Vista for sales and Go-to-Market improvements launching in FY2024, key mega-programme milestones such as regulatory submissions for PEEK Knee in India and US clinical trial approval, ongoing Magma collaboration with TechnipFMC and Petrobras for PEEK composite pipes, E-mobility customer expansions across automotive platforms, Trauma revenue exceeding £1m with new Asian customers, Aerospace Composites qualifications advancing for OEM retrofit projects, and Bond 3D impairment alongside US FDA approval for 3D printed Porous PEEK spinal cages in September 2024.

Company News

APIChat

  • seekingalpha.com

    Victrex plc (VTXPY) Q2 2026 Earnings Call Transcript

  • defenseworld.net

    Victrex PLC (OTCMKTS:VTXPF) Short Interest Down 81.6% in January

  • seekingalpha.com

    Victrex plc (VTXPF) Q4 2025 Earnings Call Transcript

  • seekingalpha.com

    Victrex plc (VTXPF) Q3 2025 Sales/ Trading Statement Call Transcript

  • seekingalpha.com

    Victrex plc (VTXPF) Q2 2025 Earnings Call Transcript

  • seekingalpha.com

    Victrex plc (VTXPF) Q4 2024 Earnings Call Transcript

  • seekingalpha.com

    Victrex plc (VTXPF) Q4 2023 Earnings Call Transcript

  • seekingalpha.com

    Victrex plc (VTXPF) Q2 2023 Earnings Call Transcript

  • gurufocus.com

    Victrex Has Growth and Value

  • seekingalpha.com

    Victrex plc (VTXPF) Q4 2022 Earnings Call Transcript

  • seekingalpha.com

    Victrex PLC (VTXPF) CEO Jakob Sigurdsson on Q2 2020 Results - Earnings Call Transcript